Patents by Inventor Gerhard Noessner

Gerhard Noessner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using therapeutic phospholipid derivatives
    Patent number: 6479472
    Abstract: A method of treating protozoal and fungal diseases is described, in which an effective amount of a compound of formula I is administered to a host having a protozoal or fungal disease.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: November 12, 2002
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Gerhard Nössner, Bernhard Kutscher, Jürgen Engel, Wolfgang Schumacher, Jurij Stekar, Peter Hilgard
  • Xanthone compounds, their preparation and use as medicament
    Patent number: 6403636
    Abstract: This invention relates to novel xanthone compounds, their preparation and use as medicament. More particularly this invention is directed to the isolation of the novel xanthone natural product sootepenseone from Dasymaschalon sootepense Craib, Annonaceae, its identification and derivatization, and the use of sootepenseone and its derivatives as anticancer agents.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: June 11, 2002
    Assignee: Zentaris AG
    Inventors: Vichai Reutrakul, Thaiwatchai Santisuk, Gerhard Noessner, Juergen Schmidt, Bernd Nickel, Thomas Klenner, Sebastian Hose
  • Phospholipid derivatives
    Patent number: 6172050
    Abstract: Phospholipid derivatives of Formula X: wherein A is the ring system in which R is a linear or branched alkyl radical having 10 to 24 carbon atoms which may contain one or more double or triple bonds; R1 and R2 are independently hydrogen or linear alkyl radicals having 1 to 3 carbon atoms; y is 0, 1, 2 or 3; m and n are independently 0 or in an integer, with the proviso that m+n is between 2 and 8; or A is a tropanio or quinuclidinio ring system, which is linked via a carbon-carbon bond and is optionally substituted by one or more methyl groups; processes for the preparation of the derivatives, and methods for treating tumors therewith.
    Type: Grant
    Filed: August 4, 1997
    Date of Patent: January 9, 2001
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Gerhard Nössner, Bernhard Kutscher, J{umlaut over (u)}rgen Engel, Wolfgang Schumacher, Jurij Stekar, Peter Hilgard